SOURCE: Chinese Hamster Ovary Cells (CHO). Adalimumab belongs to the pharmacotherapeutic group -immunosuppressants, tumour necrosis factor alpha (TNF-alpha) inhibitors- (ATC code: L04AB04). The mechanism of action of adalimumab is binding specifically to